WebApr 13, 2024 · Hepatic arterial infusion (HAI) chemotherapy is the physiologic and pharmacologic isolation of the liver. 1,2 Primary and secondary liver tumors derive their … WebSep 21, 2016 · Purpose Resection of colorectal liver metastases (CLM) in selected patients has evolved as the standard of care during the last 20 years. In the absence of prospective randomized clinical trials, a survival benefit has been deduced relative to historical controls based on actuarial data. There is now sufficient follow-up on a significant number of …
Systemic chemotherapy with or without cetuximab in patients …
WebApr 7, 2024 · A short course of chemotherapy may be administered before surgery, as long courses may injure the liver. ... Survival rates for liver cancer after resection. More than 42,000 Americans are expected to be diagnosed with primary liver cancer (cancers that start in the liver) in 2024, according to the American Society of Clinical Oncology, and ... WebApr 20, 2024 · Purpose To investigate whether perioperative hepatic arterial infusion pump chemotherapy (HAI) was associated with overall survival (OS) in patients who had a complete resection of colorectal liver metastases (CLM). Methods Patients who underwent a complete resection of CLM between 1992 and 2012 were included from a single … should the word website be capitalized
UpToDate
WebApr 12, 2024 · Unfortunately, even after a successful oncologic resection, the recurrence rate ranges from 42% to 70%. 9, 26, 27 Given our patient's high-risk disease and the … WebMay 3, 2024 · Background: A prognostic benefit of additive chemotherapy in patients following resection of metachronous colorectal liver metastases (CRLM) remains controversial. Therefore, the goal of this retrospective study was to investigate the impact of perioperative chemotherapy on disease-free survival (DFS) and overall survival (OS) of … WebOct 18, 2024 · Colorectal liver metastasis (CRLM) is a major cause of death worldwide, and the number of cases has significantly increased. Liver resection is the optimal and potentially curative treatment for CRLM, with reported 5-year posthepatectomy survival rates of 45–61%. 1, 2 However, the rate of postoperative recurrence is approximately 75%, … sbi new cmp portal page